HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombotic events in patients with congenital prekallikrein deficiency: a critical evaluation of all reported cases.

Abstract
The occurrence of thrombotic events in patients with congenital bleeding conditions has received considerable attention in recent years. The same is true for asymptomatic defects of factors of the contact phase of blood coagulation, mainly FXII. Anecdotal reports on thrombosis in patients with prekallikrein deficiency have occasionally been reported. These involved both arterial and venous thrombosis. The purpose of the present article is to analyze the stories and the clinical pictures of all 75 cases of prekallikrein deficiency published so far. Among these patients were 9 with thrombosis, 6 arterial (myocardial infarction and ischemic stroke) and 3 venous (deep vein thrombosis with or without pulmonary embolism). In 6 cases acquired thrombosis risk factors were present; in 2 cases no associated risk factors were present and in 1 case no information was supplied in this regard. One patient who presented both a stroke and a pulmonary embolism had a fatal outcome. The article clearly indicates that prekallikrein deficiency does not protect from thrombosis in spite of the severe in vitro coagulation defect.
AuthorsA Girolami, E Allemand, I Bertozzi, N Candeo, S Marun, B Girolami
JournalActa haematologica (Acta Haematol) Vol. 123 Issue 4 Pg. 210-4 ( 2010) ISSN: 1421-9662 [Electronic] Switzerland
PMID20424433 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright2010 S. Karger AG, Basel.
Chemical References
  • Prekallikrein
Topics
  • Adult
  • Blood Coagulation
  • Blood Coagulation Disorders, Inherited (blood, complications)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prekallikrein (deficiency)
  • Thrombosis (blood, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: